Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal role in advancing personalized oncology treatments.

StoryCatch Partners Acquires EmpiraMed

What You Should Know: – StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that

November 21, 2024

Gritstone Bio says personalized cancer vaccine falls short in key trial

Gritstone Bio said Monday afternoon that its personalized cancer vaccine didn’t induce more responses than standard of care in a trial for colorectal cancer, raising

April 2, 2024

AXER-204 by ReNetX Bio for Chronic Spinal Cord Injury: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.